Public Sector Pension Investment Board
PensionPosition in LGND — Ligand Pharmaceuticals Inc
CIK 1396318
MONTREAL, A8
Position in LGND
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$14,050,967
+$1,172,654 QoQ
Shares Held
70,378
+3.3% QoQ
Ownership
0.351%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Public Sector Pension Investment Board holds $340,768,011 across 30 Biotechnology names. LGND ranks #9 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
73,300 | $53,527,325 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52,037 | $40,205,867 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
92,286 | $23,839,319 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
|
331,852 | $22,609,076 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
210,280 | $22,163,512 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
41,177 | $18,387,177 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
487,257 | $16,186,677 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
366,674 | $14,751,295 |
All Filings in LGND
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,050,967 | 70,378 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $12,878,313 | 68,114 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $13,541,290 | 76,444 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $7,480,144 | 65,800 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,295,572 | 59,878 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $5,046,229 | 47,095 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,878,187 | 38,747 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,138,432 | 37,247 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,456,013 | 33,598 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,429,565 | 34,018 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,208,226 | 20,164 | Shares | Sole | 2023-11-22 | |
| 2023-06-30 | $2,100,056 | 29,127 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,076,378 | 28,227 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,950,426 | 29,198 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,579,309 | 29,400 | Shares | Sole | 2023-01-10 | |
| 2022-06-30 | $1,736,532 | 31,200 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,189,450 | 31,200 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,279,985 | 34,040 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,928,934 | 33,700 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $346,935 | 3,648 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $368,268 | 5,936 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||